Botulinum Toxin Type A in the treatment of myofascial pain related to masticatory muscles
DOI:
https://doi.org/10.5935/0104-7795.20140030Keywords:
Myofascial Pain Syndromes, Temporomandibular Joint Disorders, Masticatory Muscles, Botulinum Toxins, Type AAbstract
Objective: To systematize the scientific evidence on the efficacy of botulinum toxin type A in the treatment of myofascial pain related to masticatory muscles. Method: A bibliographical search was made in the PubMed Central Journal and Allergan Product Literature databases - botulinum toxin (APL) encompassing the past 12 years, with the descriptors: “myofascial pain,” “botulinum toxin,” “treatment,” “masticatory muscles”. The methodological quality of the studies was evaluated through the Jadad scale. Four randomized, double-blind, clinical trial studies were selected. Results: It was found that the research on the use of botulinum toxin type A for myofascial pain contributed to improving the treatments that existed until that time for this clinical condition. Conclusion: The need for more studies and forms of evaluating precisely and quantitatively is essential in order to find a definitive answer on the efficacy and safety of this treatment.
Downloads
References
Carrara SV, Conti PCR, Barbosa JS. Termo do 1º Consenso em Disfunção Temporomandibular e Dor Orofacial. Dental Press J Orthod. 2010;15(3):114-20. DOI: http://dx.doi.org/10.1590/S217694512010000300014
Leeuw R. Dor orofacial: guia de avaliação, diagnóstico e tratamento. 4 ed. São Paulo: Quintessence; 2010.
Branco RS, Branco CS, Tesch, RS, Rapoport A. Frequência de relatos de parafunções nos subgrupos diagnósticos de DTM de acordo com os critérios diagnósticos para pesquisa em disfunções temporomandibulares (RDC/TMD). Rev Dental Press Ortodon Ortop Facial. 2008;13(2):61-9. DOI:http://dx.doi.org/10.1590/S1415-54192008000200008
Sidebottom AJ, Patel AA, Amin J. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study. Br J Oral Maxillofac Surg. 2013;51(3):199-205. DOI:http://dx.doi.org/10.1016/j.bjoms.2012.07.002
Jadad AR, Moore RA, Carrol D, Jenkinson C, Reynolds JM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12. DOI:http://dx.doi.org/10.1016/0197-2456(95)00134-4
Nixdorf DR, Heo G, Major PW. Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain. Pain. 2002;99(3):465-73. DOI: http://dx.doi.org/10.1016/S0304-3959(02)00240-3
Freund BJ, Schwartz M. Relief of tension-type headache symptoms in subjects with temporomandibular disorders treated with botulinum toxin-A. Headache. 2002;42(10):1033-7. DOI: http://dx.doi.org/10.1046/j.1526-4610.2002.02234.x
De Andrés J, Cerda-Olmedo G, Valía JC, Monsalve V, Lopez-Alarcón, Minguez A. Use of botulinum toxin in the treatment of chronic myofascial pain. Clin J Pain. 2003;19(4):269-75. DOI: http://dx.doi.org/10.1097/00002508-200307000-00011
Von Linder JJ, Niederhagen B, Bergé S, Appel T. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Surg. 2003;61(7):774-8. DOI: http://dx.doi.org/10.1016/S0278-2391(03)00153-8
Lee KM, Chow J, Hui E, Li W. Botulinum Toxin Type A injection for the management of myofascial temporomandibular pain disorder. Asian J Oral Maxillofacial Sur. 2005;17(2):100-3. DOI: http://dx.doi.org/10.1016/S0915-6992(05)80032-9
Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio. 2008;26(2):126-35.
Ernberg M, Hedenberg-Magnusson B, List T, Svensson P. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. Pain. 2011;152(9):1988-96. DOI: http://dx.doi.org/10.1016/j.pain.2011.03.036
Guarda-Nardini L, Stecco A, Stecco C, Masiero S, Manfredini D. Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique. Cranio. 2012;30(2):95-102.
Sidebottom AJ, Patel AA, Amin J. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study. Br J Oral Maxillofac Surg. 2013;51(3):199-205. DOI:http://dx.doi.org/10.1016/j.bjoms.2012.07.002
Venancio Rde A, Alencar FG Jr, Zamperini C. Botulinum toxin, lidocaine, and dry-needling injections in patients with myofascial pain and headaches. Cranio. 2009;27(1):46-53.
Subcomitê de Classificação das Cefaléias da Sociedade Internacional de Cefaléia. Classificação internacional das cefaléias. 2 ed. São Paulo: Sociedade Brasileira de Cefaléia; 2004.
Amantéa DV, Novaes AP, Campolongo GD, Barros TP. The importance of the postural evaluation in patients with temporomandibular joint dysfunction. Acta Ortop Bras. 2004;12(3):155-9.
Koh H, Robinson PG. Occlusal adjustment for treating and preventing temporomandibular joint disorders. J Oral Rehabil. 2004;31(4):287-92. DOI:http://dx.doi.org/10.1046/j.1365-2842.2003.01257.x
Egermark I, Carlsson GE, Magnusson T. A prospective long-term study of signs and symptoms of temporomandibular disorders in patients who received orthodontic treatment in childhood. Angle Orthod. 2005;75(4):645-50.
Grossmann E; Collares MVM. Odontalgia associada à dor e à disfunção miofascial. Rev Soc Bras Cir Craniomaxilofac. 2006;9(1):19-24.
Dall'Antonia M, Netto RMO, Sanches ML, Guimarães AS. Dor miofascial dos músculos da mastigação e toxina botulínica. Rev Dor. 2013;14(1):52-7. DOI:http://dx.doi.org/10.1590/S1806-00132013000100013
Sposito MMM. Toxina botulínica tipo A: mecanismo de ação. Acta Fisiátr. 2009;16(1):25-37.
Murshed N, Dakka Y, Angus E. Successful treatment of severe bruxism with onabotulinumtoxin a in patients with post anoxic brain injury. Neurology 2012;78(suppl 1):P01.237.
Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005;26(5):785-93. DOI:http://dx.doi.org/10.1016/j.neuro.2005.01.017
Casale R, Tugnoli V. Botulinum toxin for pain. Drugs R D. 2008;9(1):11-27. DOI:http://dx.doi.org/10.2165/00126839-200809010-00002
Dressler D, Saberi FA, Barbosa ER. Botulinum toxin: mechanisms of action. Arq Neuropsiquiatr. 2005;63(1):180-5. DOI: http://dx.doi.org/10.1590/S0004-282X2005000100035
Rocha APC, Kraychete DC, Lemonica L, Carvalho LR, Barros GAM, Garcia JBS, et al. Dor: aspectos atuais da sensibilização periférica e central. Rev Bras Anestesiol. 2007;57( ):94-105. DOI: http://dx.doi.org/10.1590/S0034-70942007000100011
Clark GT. The management of oromandibular motor disorders and facial spasms with injections of botulinum toxin. Phys Med Rehabil Clin N Am. 2003;14(4):727-48. DOI: http://dx.doi.org/10.1016/S1047-9651(03)00044-5
Martinez JE, Grassi DC, Marques LG. Análise da aplicabilidade de três instrumentos de avaliação de dor em distintas unidades de atendimento: ambulatório, enfermaria e urgência. Rev Bras Reumatol. 2011;51(4):299-308. DOI: http://dx.doi.org/10.1590/S0482-50042011000400002
Downloads
Published
Issue
Section
License
Copyright (c) 2014 Acta Fisiátrica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
